{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:01Z","timestamp":1790688541743,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jaad.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T16:41:18Z","timestamp":1413304878000},"page":"1144-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":267,"title":["Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Julia","family":"Shlyankevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.09.012_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.det.2010.07.003","article-title":"Hidradenitis suppurativa","volume":"28","author":"Danby","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2014.09.012_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2133.1995.tb02624.x","article-title":"The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands","volume":"133","author":"Attanoos","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","article-title":"Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"68","author":"Cosmatos","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib5","first-page":"58","article-title":"Epidemiology","volume":"Vol 1","author":"Naldi","year":"2006"},{"key":"10.1016\/j.jaad.2014.09.012_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib8","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2014.09.012_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib10","first-page":"88","article-title":"Hidradenitis suppurativa and squamous cell carcinoma","volume":"28","author":"Altunay","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2014.09.012_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjd.13002","article-title":"The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease","volume":"171","author":"van der Zee","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female\u00a0patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2014.09.012_bib13","doi-asserted-by":"crossref","unstructured":"Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB. Risk-factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol doi:10.1111\/bjd.13090. Published online May 7, 2014.","DOI":"10.1111\/bjd.13090"},{"key":"10.1016\/j.jaad.2014.09.012_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.13041","article-title":"The validity of the diagnostic code for hidradenitis suppurativa in an electronic database","volume":"171","author":"Kim","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","article-title":"Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity","volume":"61","author":"Canoui-Poitrine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice: hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.09.012_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2014.09.012_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/10826084.2013.787095","article-title":"The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization","volume":"48","author":"Chen","year":"2013","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jaad.2014.09.012_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3122\/jabfm.2011.03.100200","article-title":"Coding and obesity: room to grow","volume":"24","author":"Stephens","year":"2011","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.jaad.2014.09.012_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","article-title":"Mediation of hidradenitis suppurativa by androgens","volume":"292","author":"Mortimer","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaad.2014.09.012_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.1800751011","article-title":"Endocrine basis for the clinical presentation of hidradenitis suppurativa","volume":"75","author":"Harrison","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2014.09.012_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1046\/j.1365-2133.1996.d01-901.x","article-title":"Endocrine factors in pre- and\u00a0postmenopausal women with hidradenitis suppurativa","volume":"134","author":"Barth","year":"1996","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjd.12068","article-title":"Impaired notch signaling: the unifying\u00a0mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa)","volume":"168","author":"Melnik","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.09.012_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumor necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2014.09.012_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2230.1994.tb02687.x","article-title":"Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients\u2013relationships with disease severity","volume":"19","author":"Bonifati","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib29","first-page":"115","article-title":"Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis","volume":"11","author":"Mussi","year":"1997","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.jaad.2014.09.012_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2014.09.012_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumor necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumor necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.09.012_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib34","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of\u00a0lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2014.09.012_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","article-title":"B-cell lymphoproliferation in chronic inflammatory rheumatic diseases","volume":"3","author":"Hansen","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2014.09.012_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jdv.12165","article-title":"Risk of cancer in\u00a0psoriasis: a systematic review and meta-analysis of epidemiological studies","volume":"27","author":"Pouplard","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.09.012_bib37","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archderm.139.11.1425","article-title":"Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom","volume":"139","author":"Gelfand","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","article-title":"The risk of lymphoma in patients with psoriasis","volume":"126","author":"Gelfand","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00000637-199105000-00008","article-title":"Perineal hidradenitis suppurativa: presentation of two unusual complications and a review","volume":"26","author":"Williams","year":"1991","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2014.09.012_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1308\/003588407X209392","article-title":"Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa","volume":"89","author":"Maclean","year":"2007","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.jaad.2014.09.012_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000269836","article-title":"Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa","volume":"220","author":"Lavogiez","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.09.012_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.09.012_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.09.012_bib46","first-page":"743","article-title":"Depression is a frequent co-morbidity in patients\u00a0with acne inversa","volume":"11","author":"Kurek","year":"2013","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214019124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214019124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:32:16Z","timestamp":1759271536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214019124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0190962214019124"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.09.012","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}